Summary
A federal vaccine advisory committee is discussing whether newborns should continue receiving the hepatitis B vaccine right after birth. This debate involves the Advisory Committee on Immunization Practices and is happening on December 4. Current U.S. health guidelines recommend this early vaccination, but potential changes could be made.
Key Facts
- A committee is discussing if babies should still get the hepatitis B vaccine at birth.
- The meeting is scheduled for December 4 at 8 a.m. EST.
- The hepatitis B vaccine is known to prevent cancer.
- The U.S. currently advises that all newborns receive this vaccine soon after they are born.
- Robert F. Kennedy Jr.'s committee is considering a change to this recommendation.
- The American Academy of Pediatrics still supports giving newborns the vaccine.
- The discussion takes place within the Advisory Committee on Immunization Practices.
